{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Juvenile dermatomyositis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_prednisone",
          "name": "Prednisone"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_mycophenolate_mofetil",
          "name": "Mycophenolate mofetil"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_intravenous_immunoglobulin",
          "name": "Intravenous immunoglobulin"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_hydroxychloroquine",
          "name": "Hydroxychloroquine"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_tacrolimus",
          "name": "Tacrolimus"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_belimumab",
          "name": "Belimumab"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 3
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_prednisone",
          "type": "Drug",
          "label": "Prednisone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_nec_intervening",
          "type": "Drug",
          "label": "Intravenous immunoglobulin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mycophenolate_mofetil",
          "type": "Drug",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_tp1",
          "type": "Target",
          "label": "Immune System Modulation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_inflammation",
          "type": "Pathway",
          "label": "Inflammation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_dm",
          "type": "Disease",
          "label": "Juvenile Dermatomyositis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_tp2",
          "type": "Target",
          "label": "T Cell Inhibition",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph1",
          "type": "Phenotype",
          "label": "Improved Muscle Strength",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph2",
          "type": "Phenotype",
          "label": "Decreased Inflammation",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_methotrexate",
          "target": "n_tp1",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知免疫调节作用"
        },
        {
          "source": "drug_prednisone",
          "target": "n_tp1",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "常见于自身免疫疾病治疗支持"
        },
        {
          "source": "drug_azathioprine",
          "target": "n_tp2",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "免疫抑制药物作用"
        },
        {
          "source": "drug_mycophenolate_mofetil",
          "target": "n_tp2",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "免疫系统调节药物常识"
        },
        {
          "source": "drug_nec_intervening",
          "target": "n_tp2",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "免疫相关疾病常用"
        },
        {
          "source": "drug_rituximab",
          "target": "n_tp1",
          "relation": "inhibits",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "针对B细胞的靶向药物"
        },
        {
          "source": "n_tp1",
          "target": "pathway_inflammation",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "疾病与炎症通路关联"
        },
        {
          "source": "pathway_inflammation",
          "target": "n_dm",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "免疫介导的病理通路"
        },
        {
          "source": "n_ph1",
          "target": "n_dm",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "肌肉力量改善的关键表型"
        },
        {
          "source": "n_ph2",
          "target": "n_dm",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "炎症减轻的重要指标"
        },
        {
          "source": "n_tp2",
          "target": "pathway_inflammation",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "免疫反应和炎症通路的整合"
        },
        {
          "source": "drug_etanercept",
          "target": "n_tp1",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "针对TNF的免疫调节药物"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_tp1",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "抗体机制应用于自身免疫"
        },
        {
          "source": "drug_hydroxychloroquine",
          "target": "n_tp2",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "免疫功能调节"
        },
        {
          "source": "drug_tacrolimus",
          "target": "n_tp2",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "调节T细胞活性基础常识"
        },
        {
          "source": "drug_belimumab",
          "target": "n_tp1",
          "relation": "acts_on",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "靶向B细胞机制"
        },
        {
          "source": "n_dm",
          "target": "H1",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Methotrexate在该病的应用支持"
        },
        {
          "source": "n_dm",
          "target": "H2",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Prednisone通常用于缓解症状"
        },
        {
          "source": "n_dm",
          "target": "H3",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Azathioprine被应用于相同领域"
        },
        {
          "source": "n_dm",
          "target": "H4",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Mycophenolate mofetil有效性默认为积极"
        },
        {
          "source": "n_dm",
          "target": "H5",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "IVIG用于支持疗效"
        },
        {
          "source": "n_dm",
          "target": "H6",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Rituximab显示出疗效"
        },
        {
          "source": "n_dm",
          "target": "H7",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Cyclophosphamide作为抑制剂的支持"
        },
        {
          "source": "n_dm",
          "target": "H8",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "Etanercept用于该病治疗有前例"
        },
        {
          "source": "n_dm",
          "target": "H9",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "Adalimumab在自身免疫中使用"
        },
        {
          "source": "n_dm",
          "target": "H10",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "Hydroxychloroquine的应用常识"
        },
        {
          "source": "n_dm",
          "target": "H11",
          "relation": "supports",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "Tacrolimus使用范围广"
        },
        {
          "source": "n_dm",
          "target": "H12",
          "relation": "supports",
          "weight": 0.3,
          "agent": "Proponent",
          "rationale": "Belimumab在这一领域的潜力"
        }
      ]
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种免疫调节药物对少年皮肌炎有治疗潜力和临床应用",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "所有药物具备到达相关组织的最小暴露（常识判断）"
    ],
    "uncertainties": [
      "长期副作用和疗效需进一步验证（需后续临床试验）"
    ],
    "next_focus_for_pi": [
      "确认是否需要进一步深入验证药物在表型改善中的作用"
    ]
  }
}